发明名称 USE OF ESCULENTOSIDE A FOR TREATMENT OF LIPOPOLYSACCHARIDE AND MACROPHAGE MEDIATED DISORDERS
摘要 <p>Esculentoside A is incorporated into pharmaceutical compositions and used for treating patients to modulate biological response. In particular, biological responses such as lipopolysaccharide induction of nitric oxide and macrophage activation are inhibited in order to treat a variety of disease conditions.</p>
申请公布号 WO1995003810(A1) 申请公布日期 1995.02.09
申请号 US1994007961 申请日期 1994.07.15
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址